- Home
- VXRT vs BDSX Comparison
VXRT vs BDSX Comparison
Compare VXRT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- BDSX
- Stock Information
- Founded
- VXRT N/A
- BDSX 2005
- Country
- VXRT United States
- BDSX United States
- Employees
- VXRT N/A
- BDSX N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- BDSX Precision Instruments
- Sector
- VXRT Health Care
- BDSX Health Care
- Exchange
- VXRT Nasdaq
- BDSX Nasdaq
- Market Cap
- VXRT 119.0M
- BDSX 115.4M
- IPO Year
- VXRT N/A
- BDSX 2020
- Fundamental
- Price
- VXRT $0.43
- BDSX $0.30
- Analyst Decision
- VXRT Strong Buy
- BDSX Strong Buy
- Analyst Count
- VXRT 2
- BDSX 5
- Target Price
- VXRT $3.00
- BDSX $1.75
- AVG Volume (30 Days)
- VXRT 1.8M
- BDSX 25.3M
- Earning Date
- VXRT 05-13-2025
- BDSX 05-13-2025
- Dividend Yield
- VXRT N/A
- BDSX N/A
- EPS Growth
- VXRT N/A
- BDSX N/A
- EPS
- VXRT N/A
- BDSX N/A
- Revenue
- VXRT $47,395,000.00
- BDSX $74,463,000.00
- Revenue This Year
- VXRT N/A
- BDSX $19.92
- Revenue Next Year
- VXRT N/A
- BDSX $29.03
- P/E Ratio
- VXRT N/A
- BDSX N/A
- Revenue Growth
- VXRT 433.43
- BDSX 35.76
- 52 Week Low
- VXRT $0.29
- BDSX $0.17
- 52 Week High
- VXRT $1.07
- BDSX $2.04
- Technical
- Relative Strength Index (RSI)
- VXRT 48.78
- BDSX 38.36
- Support Level
- VXRT $0.44
- BDSX $0.31
- Resistance Level
- VXRT $0.48
- BDSX $0.37
- Average True Range (ATR)
- VXRT 0.04
- BDSX 0.07
- MACD
- VXRT -0.00
- BDSX 0.01
- Stochastic Oscillator
- VXRT 37.12
- BDSX 37.90
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.